Lorraine O’Neill

818 total citations
16 papers, 321 citations indexed

About

Lorraine O’Neill is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Genetics. According to data from OpenAlex, Lorraine O’Neill has authored 16 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Rheumatology and 3 papers in Genetics. Recurrent topics in Lorraine O’Neill's work include Vasculitis and related conditions (9 papers), Urticaria and Related Conditions (3 papers) and Autoimmune Bullous Skin Diseases (2 papers). Lorraine O’Neill is often cited by papers focused on Vasculitis and related conditions (9 papers), Urticaria and Related Conditions (3 papers) and Autoimmune Bullous Skin Diseases (2 papers). Lorraine O’Neill collaborates with scholars based in Ireland, United Kingdom and Sweden. Lorraine O’Neill's co-authors include Eamonn Molloy, Douglas J. Veale, Ursula Fearon, Conor C. Murphy, Géraldine McCarthy, Richard Conway, Raashid Luqmani, Cristina Ponte, Phil Gallagher and Jennifer B. McCormick and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Lorraine O’Neill

15 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lorraine O’Neill Ireland	9	223	175	100	70	36	16	321
Alicia Rodríguez-Pla United States	10	261 1.2×	159 0.9×	122 1.2×	36 0.5×	49 1.4×	27	387
L. Magnani Italy	8	281 1.3×	247 1.4×	79 0.8×	60 0.9×	43 1.2×	26	406
Vesna Júrčić Slovenia	7	202 0.9×	130 0.7×	39 0.4×	33 0.5×	27 0.8×	28	265
Nicolò Pipitone Italy	7	196 0.9×	191 1.1×	69 0.7×	48 0.7×	34 0.9×	10	308
Natasha Dehghan Canada	7	251 1.1×	164 0.9×	58 0.6×	99 1.4×	44 1.2×	21	378
G. Bonilla Spain	4	206 0.9×	294 1.7×	135 1.4×	142 2.0×	31 0.9×	10	436
Masaki Hiraguri Japan	9	160 0.7×	248 1.4×	104 1.0×	34 0.5×	51 1.4×	15	404
V. Martínez-Taboada Spain	7	57 0.3×	130 0.7×	111 1.1×	46 0.7×	131 3.6×	11	280
Lindsay Lally United States	9	185 0.8×	153 0.9×	32 0.3×	90 1.3×	21 0.6×	19	257
E Röther Germany	10	93 0.4×	130 0.7×	113 1.1×	50 0.7×	21 0.6×	23	288

Countries citing papers authored by Lorraine O’Neill

Since Specialization

Citations

This map shows the geographic impact of Lorraine O’Neill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorraine O’Neill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorraine O’Neill more than expected).

Fields of papers citing papers by Lorraine O’Neill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorraine O’Neill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorraine O’Neill. The network helps show where Lorraine O’Neill may publish in the future.

Co-authorship network of co-authors of Lorraine O’Neill

This figure shows the co-authorship network connecting the top 25 collaborators of Lorraine O’Neill. A scholar is included among the top collaborators of Lorraine O’Neill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorraine O’Neill. Lorraine O’Neill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Murray, Kieran, Matthew Turk, Eamonn Molloy, et al.. (2020). COVID-19 and rheumatic musculoskeletal disease patients: infection rates, attitudes and medication adherence in an Irish population. Lara D. Veeken. 60(2). 902–906. 18 indexed citations

McCarthy, Cormac, Stefano Savinelli, Eoin R. Feeney, et al.. (2020). Tocilizumab therapy in individuals with COVID‐19 infection and hyperinflammatory state. Respirology. 25(10). 1090–1094. 3 indexed citations

Conway, Richard, et al.. (2020). Vision-related and health-related quality of life in patients with giant cell arteritis. European Journal of Ophthalmology. 31(2). 727–733. 5 indexed citations

Conway, Richard, Lorraine O’Neill, Géraldine McCarthy, et al.. (2019). Performance characteristics and predictors of temporal artery ultrasound for the diagnosis of giant cell arteritis in routine clinical practice in a prospective cohort.. PubMed. 37 Suppl 117(2). 72–78. 10 indexed citations

O’Neill, Lorraine, Jennifer B. McCormick, Wei Gao, et al.. (2019). Interleukin-6 does not upregulate pro-inflammatory cytokine expression in an ex vivo model of giant cell arteritis. Rheumatology Advances in Practice. 3(1). rkz011–rkz011. 11 indexed citations

Conway, Richard, Lorraine O’Neill, Phil Gallagher, et al.. (2018). Ustekinumab for refractory giant cell arteritis: A prospective 52-week trial. Seminars in Arthritis and Rheumatism. 48(3). 523–528. 69 indexed citations

Conway, Richard, Lorraine O’Neill, Géraldine McCarthy, et al.. (2018). Interleukin 12 and interleukin 23 play key pathogenic roles in inflammatory and proliferative pathways in giant cell arteritis. Annals of the Rheumatic Diseases. 77(12). 1815–1824. 36 indexed citations

Gunn, Jessica, et al.. (2018). 035 Aortic dissection secondary to giant cell arteritis in a patient on tocilizumab for established seronegative rheumatoid arthritis. Lara D. Veeken. 57(suppl_3).

O’Neill, Lorraine, et al.. (2018). Antisynthetase syndrome in pregnancy: A case and review of the literature. Obstetric Medicine. 13(2). 96–100. 5 indexed citations

10.

O’Neill, Lorraine, et al.. (2018). 050 IgG4 related disease causing left anterior descending artery stenosis successfully treated with rituximab therapy. Lara D. Veeken. 57(suppl_3). 1 indexed citations

11.

O’Neill, Lorraine & Eamonn Molloy. (2016). The role of toll like receptors in giant cell arteritis. Lara D. Veeken. 55(11). 1921–1931. 22 indexed citations

12.

Ponte, Cristina, et al.. (2015). Giant cell arteritis: Current treatment and management. World Journal of Clinical Cases. 3(6). 484–484. 42 indexed citations

13.

O’Neill, Lorraine, et al.. (2015). Migrating Polyarthritis as a Feature of Occult Malignancy: 2 Case Reports and a Review of the Literature. SHILAP Revista de lepidopterología. 2015. 1–7. 6 indexed citations

14.

O’Neill, Lorraine, Peadar Rooney, M. Kari Connolly, et al.. (2015). Regulation of Inflammation and Angiogenesis in Giant Cell Arteritis by Acute‐Phase Serum Amyloid A. Arthritis & Rheumatology. 67(9). 2447–2456. 53 indexed citations

15.

O’Neill, Lorraine, et al.. (2015). Giant Cell Arteritis and Takayasu Arteritis: Are they a different spectrum of the same disease?. Indian Journal of Rheumatology. 10(1S). 8 indexed citations

16.

Smith, Siobhán, Joan Ní Gabhann, Rowan Higgs, et al.. (2011). Enhanced interferon regulatory factor 3 binding to the interleukin‐23p19 promoter correlates with enhanced interleukin‐23 expression in systemic lupus erythematosus. Arthritis & Rheumatism. 64(5). 1601–1609. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact